Skip to main content

The 2022 Classification of GU Tumors: Don't Let the New Blue Book Make You Blue

Original release date:
December 21, 2022
Access to this course expires on:  November 15, 2025 at 11:59 PM Pacific Time
CME 12.25

Course Description
Classification, grading, staging and reporting of GU tumors have evolved significantly in recent years as molecular profiling has made a significant impact on tumor taxonomy and classification. Precision medicine and targeted therapies have emphasized the critical role of histopathological classification in prediction of prognosis and therapeutic response for cancer. These important changes are codified in the WHO Blue Book on Tumors of the Urinary System and Male Genital Organs. The 5th edition is eagerly anticipated in the spring of 2022 and is a complete revision of the 4th edition published in 2016. Expert faculty will guide attendees through the important changes and “new things” in the 5th edition WHO Blue Book in order to generate diagnoses and reports that meet the contemporary patient management needs.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize, correctly diagnose and classify new GU tumor types
  • Correctly apply new and modified grading criteria for GU cancers
  • Correctly apply new and modified staging criteria for GU cancers
  • Learn new reporting requirements for GU tumors
  • Understand the role of histomorphological classification in precision patient management

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty and IM coordinator reported no relevant financial relationships: Ming Zhou, MD, PhD, Donna E. Hansel, MD, PhD, Chia-Sui (Sunny) Kao, MD, Rajal B. Shah, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.